GlobeNewswire 29/03/2022 Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update

GlobeNewswire 28/03/2022 Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

TeleTrader 25/03/2022 Europe closes mostly higher after US, EU energy deal

GlobeNewswire 14/03/2022 Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary

GlobeNewswire 01/03/2022 Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 28/02/2022 Humacyte Announces Publication of Positive Long-Term Follow-Up Data from Phase 2 Trial of HAV™ for H...

GlobeNewswire 25/02/2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...

GlobeNewswire 24/02/2022 OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results

GlobeNewswire 24/02/2022 Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member

TeleTrader 22/02/2022 Europe closes mostly lower amid Ukraine worries

GlobeNewswire 03/02/2022 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP

GlobeNewswire 31/01/2022 Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to...

GlobeNewswire 28/01/2022 Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary ...

TeleTrader 25/01/2022 Europe shrugs off global turmoil, ends higher

TeleTrader 17/01/2022 Europe ends higher after upbeat Chinese data

TeleTrader 17/01/2022 Europe opens higher amid the Forum, COVID data

GlobeNewswire 05/01/2022 Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)

GlobeNewswire 04/01/2022 Humacyte Announces Presentation of First Preclinical Results of the HAV™ in Coronary Artery Bypass G...

GlobeNewswire 31/12/2021 CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...

GlobeNewswire 15/12/2021 Humacyte Announces Publication Highlighting the First Use of the Human Acellular Vessel (HAV™) as Ar...

GlobeNewswire 09/12/2021 Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...

GlobeNewswire 22/11/2021 Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

GlobeNewswire 16/11/2021 Humacyte Presents Preclinical Results of Small-Diameter HAV™ for Use as a BTT Shunt in Pediatric Hea...

GlobeNewswire 15/11/2021 Humacyte Presents New 12-Month Data from HAVs™ Produced Using Commercial-Scale Manufacturing System